Capillary electrophoresis improving clinical measurement of clozapine by Hsu, Pei-Chun (Lisa)
CAPILLARY ELECTROPHORESIS
IMPROVING CLINICAL MEASUREMENT
OF CLOZAPINE
A thesis submitted in partial fulfilment of the
Requirements for the Degree of
Master of Science
in Biochemistry
at the
University of Canterbury, New Zealand
Pei-Chun (Lisa) Hsu
2008
I
Table of Contents
List of Figures and Tables…………………………………………………………...…....IV
Abbreviations………………………………………………………………………………VI
Abstract…………………………………………………………………………………....VIII
Chapter 1: INTRODUCTION
1.1 Overview 1
1.2 Schizophrenia 1
1.2.1 Genetic and environmental epidemiology 2
1.2.2 Antipsychotic drug treatment for schizophrenia 3
1.2.2.1 Typical antipsychotic drugs 3
1.2.2.2 Atypical antipsychotic drugs 4
1.3 Clozapine 4
1.4 Capillary electrophoresis 7
1.4.1 Operation modes of capillary electrophoresis 9
1.4.2 Basic theory of electrophoresis 11
1.4.3 Electro-osmotic flow 12
1.4.4 Separation efficiency 14
1.5 Objective of study 15
Chapter 2: MATERIALS AND METHODS
2.1 Materials 17
2.1.1 Chemicals 17
2.1.2 Solutions and buffers 18
2.2 Methods 21
2.2.1 Blood Collection 21
2.2.2 Clozapine and N-desmethylclozapine extraction method
for human plasma 21
2.2.3 Determination of clozapine and N-desmethylclozapine
by capillary electrophoresis 23
2.2.4 Determination of clozapine and N-desmethylclozapine
by high performance liquid chromatography 24
2.3 Statistical analysis 25
II
Table of Contents
Chapter 3: RESULTS
3.1 Optimizing clozapine separation for capillary electrophoresis by
adjusting the following conditions: 26
3.1.1 BGE Concentration 26
3.1.2 BGE pH 27
3.1.3 Temperature 28
3.1.4 Applied Voltage 30
3.2 Clozapine and N-desmethylclozapine separation using the
optimal conditions 31
3.3 A comparison of protocols for plasma clozapine and
N-desmethylclozapine extraction 32
3.4 Increasing the sensitivity of capillary electrophoresis for
clozapine detection 34
3.5 The comparison of high performance liquid chromatography
and capillary electrophoresis for clozapine and
N-desmethylclozapine analysis 40
Chapter 4: DISCUSSION
4.1 The optimal condition for clozapine separation
by capillary electrophoresis 44
4.1.1
4.1.2 BGE concentration 45
4.1.3 pH of BGE 46
4.1.4 Temperature 47
4.1.5 Applied Voltage 48
4.2 A comparison of protocols for plasma clozapine and
N-desmethylclozapine extraction 49
4.3 Increasing the sensitivity of capillary electrophoresis for
clozapine detection 50
4.4 Increasing the sensitivity of capillary electrophoresis using
a 75 μm (i.d.) capillary 51
III
Table of Contents
4.5 The comparison of high performance liquid chromatography
and capillary electrophoresis for clozapine
and N-desmethylclozapine analysis 53
4.6 Instrumental issues 54
4.7 Summary 54
Acknowledgements……………………………………………………………...………..55
References………………………………………………………………………...……....56
IV
List of Figures and Tables
FIGURES
1.3.1 Molecular structure of clozapine, N-desmethylclozapine
and the internal standard protriptyline hydrochloride 6
1.4.1 Schematic of a capillary electrophoresis instrument 9
1.4.2 Dissection of a capillary under the influence of an electric field 13
3.1.1 The effectiveness of different BGE concentration
to the clozapine separation by CZE 27
3.1.2 The effectiveness of different BGE pHs on the clozapine
separation by CZE 28
3.1.3 The effectiveness of different temperatures on the clozapine
separation by CZE 29
3.1.4 The comparison between different applied voltages to the
clozapine separation by CZE 30
3.2.1 The standard curve for clozapine and N-desmethylclozapine
separation using CZE 32
3.3.1 The comparison of four different extraction methods for
clozapine separation by CZE 34
3.4.1 The comparison between the use of two separate capillaries
different in internal diameter 36
3.4.2 The electropherogram for the comparison between two
different types of capillary for clozapine separation 37
3.4.3 The effectiveness of different BGE concentrations to the
clozapine separation by using a 75 μm (i.d.) capillary 38
3.4.4 The electropherogram for the comparison between
three different BGE concentrations 39
3.5.1 The comparison between clozapine separation by CZE and HPLC 41
3.5.2 The difference plot for the comparison between clozapine
separation by CZE and HPLC 42
3.5.3 The linear regression plots and difference plots for external
quality control samples 43
V
List of Figures and Tables
TABLES
3.1.1 A summary of the optimal CZE condition for clozapine separation 31
3.4.1 A summary from the determination of clozapine level from
spiked standard by using the optimal conditions for CZE 40
VI
Abbreviations
BGE background electrolyte
CE capillary electrophoresis
CE-MS capillary electrophoresis – mass spectrometry
CGE capillary gel electrophoresis
CZE capillary zone electrophoresis
CITP capillary isotachophoresis
CIEF capillary isoelectric focusing
CV coefficient of variation
CD cyclodextrins
DTNBP1 dysbinding dystrobrevin binding-protein 1
EOF electro-osmotic flow
μe electrophoretic mobility
μEOF electro-osmotic flow mobility
EQC external quality control
EPS extrapyramidal side effects
HPFA-CE high performance frontal analysis-capillary electrophoresis
HPLC high performance liquid chromatography
HS-γ-CD highly sulphated γ-CD
i.d. internal diameter
MEKC micellar electrical chromatography
MCGE microchip capillary gel electrophoresis
MEEKC microemulsion electrokinetic chromatography
t migration time
MARTA multi-acting receptor-targeted antipsychotics
NRG1 neuregulin 1
H3PO4- phosphoric Acid
KH2PO4.H2O potassium dihydrogen phosphate buffer
Na2CO3 sodium carbonate solution
SD standard deviation
SDA serotonin-dopamine antagonists
NaH2PO4.H2O sodium dihydrogen phosphate solution
SDS odium dodecyl sulphate
NaOH sodium hydroxide
VII
Abbreviations
TD tardive dyskinesia
N theoretical plates
TCA trichloroacetic acid
μtot total mobility
ζ zeta potential
VIII
ABSTRACT
Schizophrenia is a mental disorder affecting approximately one percent of the
population worldwide. The introduction of the second generation antipsychotic drug,
atypical antipsychotic, clozapine, has demonstrated 80% reduction in suicide incident.
This drug showed effectiveness in the treatment of resistant schizophrenia, however,
high concentrations of clozapine and N-desmethylclozapine in plasma exhibit the
development of agranulocytosis, a possible lethal blood disorder. Therefore, constant
therapeutic drug monitoring is important for patients who receive clozapine.
High performance liquid chromatography (HPLC) is the current assay for clinical
clozapine measurement. A different assay, the capillary electrophoresis (CE) was
explored in this study. It was found the use of a background electrolyte (BGE)
concentration of 60 mM, pH at 2.5, temperature at 22 0C, voltage applied at 10 kV and
sample injection at 23 kV for 1.5 seconds is the optimal condition for clozapine
separation using a fused-silica capillary 75 μm in internal diameter (i.d.). The use of 75
μm (i.d.) fused-silica capillary not only permits a larger sample size, but also provided
longer detection pathlength which increased the limit of detection for CE.
One hundred and eight patients’ samples were analysed by CE and compared with
HPLC results obtained from the Canterbury Health Laboratory. A linear regression line
of 1.100 was obtained. Seven External Quality Control (EQC) samples were also
analysed and compared to the HPLC results gained from the EQC program world wide.
A linear regression line of 1.008 and 1.043 were obtained from clozapine and N-
desmethylclozapine separation respectively. The developed CE method has shown to
be a valid assay for clozapine and N-desmethylclozapine separation and a more cost
effective method compared to HPLC.
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INTRODUCTION
1.1 Overview
Schizophrenia is a mental disorder affecting approximately one percent of the
population worldwide. This mental illness is often described as a “split mind”, because
schizophrenic patients may experience hallucinations and delusions. Unfortunately,
suicide claims 10% of lives afflicted by this debilitating mental disorder (Murray et al,.
1996; Meltzer et al., 2003). Antipsychotic drug treatment includes both typical and
atypical antipsychotic. Clozapine is an atypical antipsychotic, known as a second
generation drug for schizophrenia treatment. Clozapine has been shown to give
improvement in positive and negative psychotic symptoms, and it shows high
effectiveness in treatment-resistant schizophrenia patients (Breier et al., 1994, Iqbal et
al., 2003). However, it was found approximately 1-2% of patients who received
clozapine, without monitoring, developed agranulocytosis, a potentially fatal blood
disorder (Amsler et al., 1977). The major metabolite of clozapine, N-desmethylclozapine,
also exhibits toxici effects at high concentrations (Gerson et al., 1994). Therefore, it is
relatively important to perform regular therapeutic drug monitoring for schizophrenic
patients who receive clozapine.
High performance liquid chromatography (HPLC) is the current method for clozapine
measurement at Canterbury Health Laboratories. This study will explore a different
technique, capillary electrophoresis (CE), for clozapine quantification from plasma
samples. A protocol for CE will be developed in this study, and the results will be
compared with HPLC.
1.2 Schizophrenia
Schizophrenia is one of the top ten causes of disability in developed countries (Murray
et al,. 1996), and found in one percent of the population worldwide. People with
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schizophrenia behave differently, they may hear ‘voices’ or talk to things that do not
exist, they may also become ‘flat’ and, eventually, socially withdrawn. Therefore, the
effects of schizophrenia have been a great concern for many years. It is estimated 50%
of the patients with schizophrenia have attempted suicide, and 10-13% of them have
succeeded (Meltzer et al., 2003).
Eugene Bleuler is the first person to characterise the symptoms of schizophrenia into
two categories, “positive” and “negative” symptoms. “Positive” symptoms are additional
sensations or feelings of patients such as hallucinations, delusions and thought
confusions. “Negative” symptoms are those normal abilities or feelings considered
reduced or absent; such are alogia (poverty of speech), affective flattening (reducing
emotional expression), and avolition (social dysfunction). “Cognitive” symptoms
including disorganised thinking, poor memory, poor concentration and difficulty in
understanding are criteria also considered in diagnosing schizophrenia in recent years
(Black and Boffeli, 1989; Capuano et al., 2002). The Diagnostic and Statistical Manual
of Mental Disorders DSM-IV-TR is used in diagnosing schizophrenia.
1.2.1 Genetic and Environmental Epidemiology
The causes of schizophrenia are considered to be a combination of many elements,
including environmental and genetic factors. It has been known for many years that
schizophrenia runs in families. Therefore, it is not surprising such a disorder is
inheritable. There is strong evidence showed two genes to schizophrenia which encod
dysbinding dystrobrevin binding-protein 1 (DTNBP1) and neuregulin 1 (NRG1). The
mechanisms of how these genes correlate to schizophrenia are currently unknown.
Many studies significantly suggested that environmental stressors strongly contributed
to the development of schizophrenia (Cardno and Gottesman, 2000). Several other
factors were also reported to increase the risk of schizophrenia, such as maternal
infections, influenza, genital infection, taxoplasmosis gondii parasite exposure, alcohol
toxicity and stress during pregnancy. Intake of cannabis and other street drugs may also
increase the risk of schizophrenia development (Arendt et al. 2005). Predisposition in
one gene is insufficient to cause such a disorder; it is a complex network where
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combinations of many gene interactions with the aid of environmental factors contribute
to the risk of triggering schizophrenia (Tsuang, 2000). Multiple hypotheses regarding
neurotransmitter levels have arisen to explain the etiology of schizophrenia, such as the
dopamine (Capuano et al., 2002), glutamate (Konradi and Heckers, 2003), serotonin
(Breier 1995), and the recent N-3 fatty acid hypothesis (Koichi, 2006).
1.2.2 Antipsychotic Drug Treatment for Schizophrenia
Medication therapies provide the most ameliorative properties on positive and negative
symptoms in schizophrenia. There are two groups of antipsychotic drugs, “typical”
antipsychotic drugs and “atypical” antipsychotic drugs. Typical antipsychotics (also
referred to as conventional antipsychotics) are the “first-generation” antipsychotic drugs,
which improve positive symptoms of schizophrenia. Nevertheless, 30-60% of patients
given “typical” antipsychotics exhibit a wide range of side effects, often in the central
nerve system, cardiovascular system, and endocrine system (Iqbal et al., 2003). These
patients are grouped as “treatment resistant” schizophrenics, and eventually withdrawn
from typical antipsychotic treatment. Atypical antipsychotics are the “second-generation”
drugs, which are more effective than typical antipsychotic drugs. Atypical antipsychotic
drugs alleviate not only positive symptoms, but also negative and cognitive symptoms.
What separates atypical antipsychotics from typical antipsychotic drugs are that they do
not cause extrapyramidal side effects (EPS) (movement disorder - similar to Parkinson’s
disease), as well as other side effects such as tardive dyskinesia (TD) (Kapur and
Remington, 2001).
1.2.2.1 Typical Antipsychotic Drugs
There are several varieties of typical antipsychotic; chlorpromazine, fluphenazine,
haloperidol, molindone, thiothixene, thioridazine, trifluoperazine, loxapine, perphenazine,
prochlorperazine, and pimozide. However, typical antipsychotic drugs often worsen
negative symptoms and cause side effects, such are as EPS, TD, elevated prolactin,
galactorrhoea in female and gynecomastia in male. Other pharmacological side effects
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also include dry mouth, constipation, urinary retention, cognitive dumbness, orthostatic
hypotension, and weight gain. The mechanisms of these side effects are not fully
understood, however, they are probably due to the non-selective high D2 receptors
potency in mesolimbic and striatal regions of the brain. High D2 receptor antagonism
also results in reducing dopamine concentration in the mesocortical region of the brain,
which leads to worsening negative and cognitive symptoms (Serretti et al., 2004).
1.2.2.2 Atypical Antipsychotic Drugs
Atypical antipsychotic drugs include amisulpride, aripiprazole, clozapine, fluoxetine,
melperone, olanzapine, paliperidone, quetiapine, risperidone, sertindole, ziprasidone,
and zotepine. These drugs are distinct from typical antipsychotics due to the lack of
EPS and TD expression. They are classified into four groups; the serotonin-dopamine
antagonists (SDA), multi-acting receptor-targeted antipsychotics (MARTA), D2/D3
receptor antagonists, and the partial dopamine receptor agonists. SDA show high
selectivity for D2 receptors and serotonin 5-TH2A receptors. MARTA exhibit high affinity
for D2 receptors and 5-HT receptors, as well as other neurotransmitter receptors, such
as adrenergic, muscarinic, histaminic, and cholinergic receptors (Horacek et al., 2006,
and Iqbal et al., 2003). Patients who have treatment resistant schizophrenia often
showed improvement after they received atypical antipsychotic drugs.
1.3 Clozapine
Out of all the atypical antipsychotic drugs, clozapine was found to be the most effective
drug for alleviating both positive and negative symptoms. Clozapine (8-chloro-11-(4-
methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine) was first developed in 1961
(Hunziker et al., 1963; Iqbal et al., 2003) (Figure 1.4.1). It is a tricyclic dibenzodiazepine-
derivative, atypical antipsychotic drug which exhibits low risk for EPS and TD (Kapur
and Remington, 2001). The oral bioavailability of clozapine is about 60%, while 50% is
excreted through urine, and 30% through faeces. Around 95% of clozapine is bound to
plasma proteins. The maximum plasma concentration is reached in 1.5 – 3.6 hours, and
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the steady-state plasma concentration is reached in less than 10 days. The half-life of
clozapine is 14–16 hours, and total body clearance occurs at a rate of 30-57 L per hour
(Wagstaff and Bryson, 1995). The plasma level of clozapine is also varied by many
factors, such as smoking, gut absorption, hepatic metabolism, age, sex, and ethnic
origin. These lead to difficulties in the determination of clozapine dosage. Therefore,
clozapine concentrations in plasma have been used to optimise drug therapy. The
optimal plasma concentration of clozapine was reported between 1070-1840 nM for
clinical activity (Hiemke et al., 2000). A recent case report has found that relapses, such
as increasing both positive and negative symptoms, were occurring at serum clozapine
levels lower than 420 nM. The range of serum clozapine levels where schizophrenic
patients were found to be most stable was between 660 nM and 2000 nM. Furthermore,
increased adverse effects were found at a serum clozapine level of 3540 nM (Ulrich et
al., 2003).
Clozapine is metabolised in the liver via cytochrome P450, mainly by CYP1A2, CYP3A4,
and CYP2D6. Genetic variances of these enzymes within individuals can alter the
pharmacokinetic properties of clozapine metabolism. Patients who are defined as slow
metabolisers by the activity of these enzymes may exhibit side effects when
augmentation therapy of clozapine or other medications are applied (Prior et al., 1999).
It was found that clozapine can be metabolised into more than twelve different
metabolites which do not appear to have any significant clinical activities. The major
metabolic pathway is the phase I pathway, which results in demethylation or
hydroxylation on position 7 or 8 of the benzodiazepine aromatic ring (Dain et al., 1997).
The main metabolite in plasma and urine is N-desmethylclozapine, which was found to
be pharmacologically active (Jann et al., 1993 and Dain et al., 1997) (Figure 1.4.1). The
mean concentrations of N-desmethylclozapine in plasma are 440-1320 nM (Liu et al.,
1996). The ratio of N-desmethylclozapine and clozapine has seemed to vary widely,
within a range of 0.6-1.0 by Wagstaff and Bryson (1995). An investigation of 58 patients
who received clozapine has shown correlation between plasma N-desmethylclozapine
concentration and granulocyte counts (Comb et al., 1997). Gerson et al (1994) reported
that N-desmethylclozapine may exhibit bone marrow toxicity. An in vitro study by
Gerson et al, suggested that N-desmethylclozapine has the potential for clozapine-
induced agranulocytosis. Unfortunately, the concentration of N-desmethylclozapine
cannot be precisely predicted by the concentration of its parent drug, therefore
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therapeutic drug monitoring for N-desmethylclozapine is relatively important to identify
patients who might be at the risk of bone marrow suppression, as well as
agranulocytosis development.
Figure 1.3.1 Molecular structure of Clozapine, N-desmethylclozapine and the internal
standard protriptyline hydrochloride (Adapted from Raggi et al., 2001;
Shim et al., 1997)
The fundamental mechanism of how clozapine effectively reduces both positive and
negative symptoms, and lowers the propensity to produce EPS remains uncertain.
However, clozapine exhibits as a MARTA-type of antipsychotic drug, which has a
unique receptor binding mechanism. Clozapine shows low antagonistic effects for the
dopamine D2 receptor, but high affinity for dopamine D1 and D4 receptors, which is in
contrast to typical antipsychotic drugs. Clozapine also shows high antagonistic effects
on the serotonin 5-HT2 receptors, which resulted in increasing dopamine level in the
stratum and reduced EPS. Clozapine also has an antagonistic effect toward histamine
H1, muscarinic M1 and adrenergic α1- and α2-receptor. (Wagstaff and Bryson, 1995 ;
Horacek et al., 2006 ; Iqbal et al., 2003 ; Gerlach and Peacock, 1995).
Out of all atypical antipsychotic drugs, clozapine demonstrated the most promising
results. Clozapine has showed efficacy toward treatment-resistant schizophrenia by
reducing positive, negative, and cognitive symptoms. A research study has
demonstrated 30-60% of treatment-resistant schizophrenic patients respond to
clozapine (Iqbal et al., 2003). A non-blinded study also showed that 81% of patients
respond to clozapine within 6 months of commencement of treatment (Meltzer et al.,
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1989). A study from Reid et al (1998) has demonstrated that the suicide rate was
reduced by 80% when compared with patients receiving any antipsychotic drug. Even
though the mechanism of preventing suicide incidents by clozapine is currently
unknown, the beneficial outcomes from clozapine prove it to be the first-line therapeutic
drug out of all atypical antipsychotic.
It was reported in the 1970’s that approximately 1-2% of patients who received
clozapine developed agranulocytosis (granulocyte count < 500/mm3), a potentially fatal
blood disorder which results in low white blood cell count with a mortality rate of 3-4%
(Amsler et al., 1977 ; Gerson, 1994). Therefore, clozapine was removed from the
market in 1975. However, the benefits and efficacy provided by clozapine far outweigh
its risks, clozapine was reintroduced in 1990’s. Accepting that the use of clozapine
exposes schizophrenic patients to certain risks, regular therapeutic drug monitoring and
white blood cell count monitoring is necessary for those who receive clozapine.
1.4 Capillary Electrophoresis
Electrophoresis is a technique for charged molecules to be separated based on their
charge to mass ratio by attraction or repulsion in an electric field. That is, cations move
toward the negative electrode (cathode) due to its positively charged property, and
anions move toward the positive electrode (anode) due to its negatively charged
property. This process occurs in a medium such as paper, cellulose acetate or agarose
gels. Conventional electrophoresis is a simple, low cost and widely used technique.
However, quantification of electrophoresis is often difficult and imprecise. Furthermore,
electrophoresis is often slow in process, and exhibits indirect detection only. Capillary
Electrophoresis (CE) is a merged technique derived from traditional electrophoresis and
high performance liquid chromatography (HPLC). CE was first developed by Hjērten in
1967 as a simple homemade system using a 3 mm internal diameter (i.d.) capillary.
Fourteen years later, Jorgenson and Lukacs developed the first instrument resembling
modern CE. Jorgenson and Lukacs had demonstrated the potential of CE as an
analytical technique by efficient separations of amino acids, peptides and urinary
amines using a 75 μm (i.d.) open tube glass capillary (Jorgenson and Lukacs,
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1981). The advantage of a CE system compared to conventional electrophoresis is that
it provides an on-line detection system and the result output appears as a
chromatograph, similar to HPLC. Other advantages for CE are the minute amounts of
sample required (estimated 1 to 50 nL injected), faster separation, high efficiency,
reusable capillary, and less labour-intensive compared to conventional electrophoresis.
The main advantages of CE over HPLC are the inexpensive capillaries compared to
expensive HPLC columns and reduced organic solvent use, which is a considerable
save in cost.
A typical commercial CE instrument consists of the following main components; a high
voltage power supply (up to 30 kV), a vial carousel, a capillary, a capillary cartridge, a
capillary thermostat, a diode-array detector, electrodes, and a computer which connects
to the CE (Figure 1.5.1). The separation takes place in a narrow internal diameter (i.d.)
capillary (usually 25 to 100 μm) in a CE system. A strong electrical field is applied to the
capillary (up to 500 V cm-1) which inevitably generates heat. Therefore, the use of
narrow i.d. capillaries is relatively important in CE, as they have large surface area-to-
volume ratios which provide constant heat dissipation in order to suppress undesirable
temperature gradients throughout the capillary (Jorgenson and Lukacs, 1981). Capillary
thermostatting is used to controlling the temperature of a capillary. The run buffer, also
known as the background electrolyte (BGE), provides stability of pH variations during
analysis. When both ends of a capillary are placed in two separate BGE reservoirs,
along with the electrodes, the passage of electric current (ions) of BGE provides
sufficient electrical conductivity. The sample is injected into the capillary by simply
replacing the BGE reservoir at the inlet (anode) with a sample reservoir, and applying
either electric potential (electrokinetic injection) or external pressure (hydrodynamic
injection) across the capillary. After replacing the BGE reservoir, a voltage is applied,
and the separation performed based on the difference in analyte velocity in an electric
field. Optical on-line UV detection is performed directly through the capillary wall near
the cathode at the detection window.
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Figure 1.4.1 Schematic of a capillary electrophoresis instrument
1.4.1 Operation Modes of Capillary Electrophoresis
There are several major operation modes for CE systems. These modes are; capillary
zone electrophoresis (CZE), micellar electrical chromatography (MEKC), and capillary
gel electrophoresis (CGE). CZE is the principle mode for CE. It is widely used for amino
acid, peptides, ions, enantiomers and protein separation. CZE is a simple method
where the capillary is filled with BGE. Analytes separate into different zones based on
their charge to mass ratio. Cationic species will elute first, followed by neutral species,
and anionic species will elute last. The addition of cyclodextrins (CD) and macrocyclic
oligosaccharides to the BGE was found to enhance enantiomer separation; α-CD is
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useful for a single ring aromatic molecule separation, β-CD is useful for one or two ring
aromatic molecule separation, and γ- CD is used for larger and more complex
molecules. Kvasniˇcka et al, (2005) compared α-CD, β-CD and highly sulphated γ-CD
(HS-γ-CD) for separation of butorphanol and cycloamine. It was found the cavities of α-
and β-CD are too small for butorphanol and cyclozmine, whereas HS-γ-CD has a larger
inner cavity for analytes binding. Even though the use of α-CD and β-CD exhibit longer
migration time for separation, the enantiomers of these analytes were successfully
separated. The separation efficiency was further enhanced by introducing HS-γ-CD.
MEKC and CGE are the separation techniques under the concept of CZE. If the
separation is not possible by varying the BGE pH or concentration, MEKC is an
alternative technique for CE. MEKC is a useful operation mode for neutral and charged
species separation by addition of various surfactants. Anionic surfactants such as
sodium dodecyl sulphate (SDS) have successfully been introduced for various anti-
inflammatory drug separations, for example paracetamol and phenacetin (Terabe,
1989). Le et al (2005) have demonstrated separation of twelve phenothiazines and
their metabolites using glycol monododecyl ether as a non-ionic surfactant with the
MEKC technique. The addition of crown ethers to the BGE have shown efficient
separation for inorganic cationic species such as sodium, calcium and magnesium ions
(Riviello and Harold, 1993). A mixture of bile salt, phosphatidylcholine and fatty acid
micelles were successfully introduced for various drug separations e.g. ibuprofen, and
diclofenac (Schwarza et al., 1998). CGE is a technique similar to conventional gel
electrophoresis but using a capillary as the medium. CGE has a polymer matrix in the
capillary. Examples of the polymer matrix are polyacrylamide, agarose, and
methylcellulose. CGE is widely used for oligonucleotides (Szilagyi et al., 2007), DNA
fragments (Végvári and Hjertén, 2002), and proteins separation (Hjertén et al., 2004).
There are several other operation modes for CE; capillary isotachophoresis (CITP)
(Kvasnička et al., 2007), capillary isoelectric focusing (CIEF) (Wu and Huang, 2006),
microchip capillary gel electrophoresis (MCGE) (Kim et al., 2005), microemulsion
electrokinetic chromatography (MEEKC) (Zhou et al., 1999), high performance frontal
analysis-capillary electrophoresis (HPFA-CE) (Wan et al., 2005), and capillary
electrophoresis – mass spectrometry (CE-MS) (Lagarrigue et al., 2008) for example.
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Each operation mode is uniquely designed depending on the properties of the desired
analysis.
1.4.2 Basic Theory of Electrophoresis
The separation process by electrophoresis is based on the analytes movement through
a fluid solution in an electric field. In the solution, the current is carried by ions. The
conductivity of this solution depends on the concentration and the mobility of the ionic
species in an electric field. Therefore, the conductivity of a solution is described by the
Ohm’s Law.
E = I R (1)
W = I2 R (2)
where E is the applied electric field, I is the current in a solution, R is the resistance of
the solution, and W is power measured is watts. Equations (1) and (2) demonstrate the
electric field is proportional to the current, and heat can be generated by current flows.
The steady state of the electrophoresis process is defined by the equilibrium of applied
electric force and the frictional force for an ion (Stokes’s Law). The electrophoretic
mobility ( μe ) is the velocity of an ion moving in an applied electric field. By combining
these two characteristics for an electrophoreticprocess, the equation for describing
electrophoretic mobility ( μe ) is given as;
ηπ
ν
μ
r6
q
=
E
=e (3)
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where ν is the ion velocity, E is the applied electric field, q is the ion charge, r is the ion
radius, and η is the viscosity of a solution. Equation (3) shows that the electrophoretic
mobility is governed by the charge to size ratio of an ion, that is, large lower charged
ions have low mobility and small highly charged ion have high mobility.
1.4.3 Electro-Osmotic Flow
In theory, only cationic species are able to migrate towards the cathode and travel
through the detector. However, in practice, non-ionic and anionic species are also able
to migrate toward to the cathode with the aid of strong electro-osmotic flow (EOF). The
EOF, also called the electroendosmotic flow, is the fundamental component of a CE
system. EOF is the bulk of liquid (ie. BGE) which moves toward the cathode under the
application of an electric field (Figure 1.5.3). An uncoated fused-silica capillary is made
of highly cross-linked polymers of silicon dioxide. The silanol groups of these polymers
are readily dissociated and become party deprotonated at the capillary wall by flushing
with strong base, such as 1M of sodium hydroxide. Filling the capillary with BGE will
attract positively charged ions of the BGE to the negatively charged capillary wall. This
generates an electrical double layer and creates a potential difference close to the
capillary wall. The potential difference of the capillary wall to the EOF is called the zeta
potential ( ζ ). The inner layer is the rigid layer called the Helmholtz layer. This rigid
layer consists of cations which are tightly bound and adsorb to the negatively charged
capillary wall. The diffuse layer, also called the Debye-Hϋckel layer, is a mobile region 
affluent in cations (Wätzig and Günter 2003). This layer is free to migrate and drag the
bulk solution, including analytes, towards the cathode (Figure 1.5.3). The centre region
of a capillary is electrically neutral since the zeta potential is no longer applied in this
section. The flat flow of EOF is evenly distributed throughout the capillary, which is a
unique feature of CZE.
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Figure 1.4.2 Dissection of a capillary under the influence of an electric field.
The EOF mobility is dependent on the zeta potential of the capillary wall, the dielectric
constant and the viscosity of BGE. This phenomenon is described by the Helmholtz-
Smoluchowski formula;
πη
εζ
μ
4
=EOF (4)
where ε is the dielectric constant of the BGE, ζ is the zeta potential, and η is the
viscosity of the BGE. Note that the EOF mobility is proportional to the zeta potential and
inversely proportional to the viscosity of the BGE (Wang et al., 2007).
The total mobility ( μtot ) of a solution in a capillary is the sum of the
electrophoretic mobility of its component analytes ( μe ) and the EOF mobility ( μEOF ) .
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The relationship of an analytes migration time ( t ) to the mobility and capillary length
can be described by the following equation(Huang et al., 1989);
V)+(
L
=t
EOFe μμ

(5)
where ℓ is the effective capillary length, L is the total capillary length, V is the applied
voltage, μe is the electrophoretic mobility and μEOF is the EOF mobility. The effective
capillary length is the distance from the injection end of a capillary to the detection
window (Figure 1.5.1). An equation (5) show the use of short capillary length and high
voltage application is the key to a short analysis. There are several factors that can
influence the EOF and, consequently, the analysis time. These include the BGE
concentration, the applied voltage, and the temperature. The analysis time decreased
with increasing voltage and temperature. Since the viscosity of the BGE is dependent
on temperature, increasing temperature will result in reducing the viscosity of BGE. This
results in greater total mobility and reduction in the analysis time (Equation 3, 4, and 5).
The analysis time is also effected by the BGE concentration. Dilute BGE is less viscous,
therefore, the use of dilute BGE will result in decreasing the analysis time. However,
these parameters can influence the separation itself, and therefore the resolution and
precision of the analysis. Although short analysis time was one of the primary goals for
this study, the resolution and precision should also be carefully take into an account.
1.4.4 Separation Efficiency
The efficiency in CE system is calculated in theoretical plates ( N ). In order to improve
the separation, maximum efficiency must be achieved. Zone length in CZE is
dependent on the dispersion, thus the dispersion must be controlled. In a perfect
system, analyte zone broadening is regard as longitudinal diffusion. There are many
variances of dispersion involved in longitudinal diffusion. These include molecular
diffusion, injection, temperature gradients, wall absorption, detection, and
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electrodispersion. Assuming the molecular diffusion is the only source of zone
broadening, the efficiency was described by Jorgenson and Lukacs (1981);
D2
V
=N
totμ
(6)
Where N is the maximum theoretical plate, μtot is the total mobility, V is the applied
voltage, ℓ is the effective capillary length, D is the diffusion coefficient of the analyte, and
L is the total capillary length. Separation efficiency is independent of the capillary length,
in theory. This is because the length of analyte zone is short compared to the total
capillary length. However, the injected amount can be affected by the capillary length. It
is difficult to quantify the amount of analyte injected, because it depends on the μtot,
injection voltage, injection time, capillary radius, sample concentration, and capillary
length. The injection amount is estimated to be from 1 to 50 nL in a CE system.
1.5 Objective of Study
As mentioned earlier, high concentrations of clozapine and N-desmethylclozapine in
plasma may lead to the development of agranulocytosis or other side effects in the
schizophrenic patient. Agranulocytosis is a potentially fatal blood disorder with a
mortality rate of 3-4% (Gerson et al., 1994; Ulrich et al., 2003). Due to this possible life
threatening side effect, regular therapeutic drug monitoring is important for patients who
receive clozapine as their primary antipsychotic drug.
HPLC is the current technique performed at Canterbury Health Laboratories for
therapeutic drug monitoring of clozapine. This method was developed from a
combination of two research works by Volpicelli et al, (1993) and Lovdahl et al, (1991).
Large volumes of mobile phase are needed for this HPLC method. The mobile phase
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includes the use of acetonitrile, which is expensive in cost, and heptane-sulphonic acid,
is also expensive. C8 HPLC columns as used in this assay are also relatively expensive.
This study will explore an alternative method by using CE for clozapine analysis. The
use of the CE technique aims to reduce the cost of solvent use, as well as replacing
expensive HPLC column with inexpensive capillaries. Small volumes of phosphate
buffer are the major solutions required for CE. A new protocol for CZE will be developed
in this study by adjusting various parameters that may influence the EOF of a capillary.
These parameters include BGE pH, BGE concentration, temperature, and applied
voltage. Serum spiked with clozapine and N-desmethylclozapine will be analysed by
CZE using the developed optimal conditions. Patient samples will also be analysed by
CZE in this study, and compared with their HPLC results.
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MATERIALS AND METHODS
2.1 Materials
2.1.1 Chemicals
All reagents used in this study were of analytical grade or better.
Acetonitrile Mallinckrodt Chemicals
Clozapine Sigma
n-Desmethylclozapine Sigma
Dichloromethane Mallinckrodt Chemicals
Ethyl acetate Merck
1-Heptane sulphonic acid Sigma Chemical Co.
n-Hexane Merck
Isopropanol alcohol Merck
Methanol Merck
3-Methyl-1-butanol Sigma-Aldrich
Phosphoric acid Merck
Potassium dihydrogen phosphate Merck
Protriptyline hydrochloride Sigma
Sodium carbonate Anala-R®
Sodium dihydrogen phosphate Baker Chemical Co.
Sodium hydroxide Merck
Trichloroacetic Acid Merck
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2.1.2 Solutions and Buffers
A. Capillary Electrophoresis Reagents
Sodium Dihydrogen Phosphate Solution (NaH2PO4.H2O)
A stock solution of 1 M NaH2PO4.H2O solution was prepared by dissolving 13.799g of
NaH2PO4.H2O in 100 mL of deionised water. This was stored at room temperature.
Phosphoric Acid (H3PO4-)
A stock solution 1 M of H3PO4- was prepared by adding 5 mL of concentrated
phosphoric acid into 100 mL of deionised water. This solution was stored at room
temperature.
Sodium Hydroxide (NaOH)
A stock solution of 1 M NaOH was prepared by dissolving 4 g of NaOH into 100 mL of
deionised water. A 0.1 M NaOH solution was prepared by diluting 10 mL of 1 M NaOH
into 100 mL of deionised water. These solutions were stored in room temperature.
B. High Performance Liquid Chromatography Reagents
Sodium Hydroxide (NaOH)
A 0.4 M of NaOH solution was prepared by dissolving 1.6 g of NaOH in 100 mL of
deionised water. This solution was stored at room temperature.
Potassium Dihydrogen Phosphate Buffer (KH2PO4.H2O)
The phosphate buffer was made up by dissolving 4.08 g of KH2PO4.H2O in 600 mL of
deionised water. The solution was adjusted to pH 2.7 with 2 M of phosphoric acid. This
solution was then diluted to 1 L with deionised water. The phosphate buffer was stored
in room temperature.
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Mobile Phase
The mobile phase for HPLC in this assay contained 310 mL of phosphate buffer, 190
mL of acetonitrile, and 1 g of 1-heptanesulphonic acid. The solution was made up in a
500 mL beaker, and was dissolved completely using a magnetic stirrer. The solvent was
filtered through a 0.5 μm micro filter, and degassed under vacuum.
C. Clozapine / N-Desmethylclozapine / Protriptyline Hydrochloride Preparation
Clozapine Standard (Stock)
A 1 mM clozapine standard solution was made up by dissolving 32.7 mg of clozapine in
100 mL of methanol. This stock clozapine solution was stored in the freezer at -20 0C.
N-Desmethylclozapine Standard (Stock)
A 1 mM N-desmethylclozapine stock solution was made by dissolving 31.8 mg of N-
desmethylclozapine in 100 mL of methanol. The stock solution was stored in the freezer
at -20 0C.
Clozapine / N-Desmethylclozapine Intermediate Standard
A 100 μM intermediate clozapine / N-desmethylclozapine standard was prepared by
diluting 1 mL of each stock solution up to 10 mL of methanol. This intermediate
standard solution was not stored.
Clozapine / N-Desmethylclozapine Working Standard (in drug free serum)
A set of 1000, 2000 and 4000 nM working clozapine / N-desmethylclozapine standards
were prepared by pipette 500 μL, 1 mL and 2 mL of intermediate standard and made up
to 50 mL with human drug free serum. The serum sample was mixed completely by the
use of a magnetic stirrer, and was stirred overnight. These working standards were
divided into aliquots and stored in the freezer at -20 0C.
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Clozapine Standard / N-Desmethylclozapine Working Solutions
A 120 μM intermediate clozapine / N-desmethylclozapine standard was prepared by
diluting 1.2 mL of each stock solution to 10 mL with methanol. A series of 3000, 6000,
and 12000 nM working solutions were made by diluting 300 μL, 600 μL, and 1.2 mL of
the 120 μM intermediate standard to 10 mL with 50% methanol. These solutions were
stored in the fridge at 5 0C.
The concentrations of these working solutions are equivalent to the concentrations of
the working standards (in drug free serum) taking into account the concentration effect
of three during extraction.
Protriptyline Hydrochloride (stock- internal standard)
A 250 mg/L of protriptyline hydrochloride solution was prepared by dissolving 25 mg of
protriptyline hydrochloride into 100 mL of deionised water. This stock solution was
stored in the fridge at 5 0C.
Protriptyline Hydrochloride Working Solution (internal standard)
A 25 mg/L working internal protriptyline hydrochloride solution was prepared by diluting
10 mL of the stock internal standard to 100 mL with deionised water. This internal
standard was stored in the fridge at 5 0C. An 8.33 mg/L solution of protriptyline
hydrochloride was also prepared by diluting the 25 mg/L internal standard one in three.
D. Reagents used for serum extraction process
Sodium Carbonate Solution (Na2CO3)
A 100 mL solution of Na2CO3 was prepared by dissolving 1.06 g of anhydrous Na2CO3
in deionised water. This solution was stored in the fridge at 5 0C.
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Potassium Dihydrogen Phosphate Buffer Solution (KH2PO4)
A 45 mM buffer solution was prepared by dissolving 0.61 g of KH2PO4 in 100 mL of
deionised water. The pH was adjusted to 2.8 with concentrated phosphoric acid, and
was stored in the fridge at 5 0C.
2.2 Method
2.2.1 Blood Collection
Drug free serum was collected from hemachromatosis patients and was stored at -20
0C until used in experiments for working standards. Patient samples (either serum or
plasma) were obtained from the Toxicology department laboratory at Canterbury Health
Laboratories. Serum was obtained from coagulated gel tubes and plasma was obtained
from anti-coagulated heparin tubes. Patient samples were stored at 5 0C until used in
the analysis (maximum storage time was one week). External quality control samples
were stored at -20 0C.
2.2.2 Clozapine and N-desmethylclozapine Extraction Methods for Human
Serum and Plasma
A. Clozapine Extraction Method A (Toxicology lab menu)
A 900 μL of working standard or patient’s sample was aliquoted into a 10 mL plastic
centrifuge tube, followed by addition of 50 μL of the working internal standard solution
(protriptyline hydrochloride). Ethyl acetate (4 mL) was added as an extraction solvent
and shaken vigorously for one minute. The mixture was centrifuged for five minutes at
3500 rpm before transferring the top organic phase into a clean 10 mL plastic centrifuge
tube. This organic phase solvent was evaporated to dryness under a soft stream of dry
nitrogen gas in the heating block. Following this, the residual working standard or
patient’s sample was reconstituted with 300 μL of 50% methanol. The sample was
vortex mixed for 30 seconds and then transferred to an eppendorf microfuge tube,
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followed by centrifugation for 5 minutes at 14,000 rpm in a microfuge. 200 μL of each
sample was transferred into an autosampler vial, which contained 20 μL of buffer.
B. Clozapine Extraction Method B (Dusci et al., 2002)
This assay was employed by Dusci et al., (2002) to extract Olanzapine from human
plasma samples. N-desmethylclozapine was used as an internal standard in this assay
for determining olanzapine by HPLC. Olanzapine is an atypical antipsychotic drug that
has a very similar molecular structure to clozapine. In contrast to method A,
hexane:dicloromethane was used as an extraction solvent in this assay.
Working standard (600 μL) and 50 μL of working internal standard (protriptyline
hydrochloride) were pipetted into a 10 mL screw-capped glass tube containing 8 mL of
extraction solvent (85:15 v,v- hexane:dicloromethane) and 500 μL of 0.1M sodium
carbonate. The mixture was shaken vigorously for five minutes and centrifuged for 5
minutes at 3500 rpm. Organic phase was then transferred to another clean 10 mL
screw-capped glass tube and back extracted into 200 μL of potassium dihydrogen
phosphate buffer (45 mM, pH 2.8). The mixture was then centrifuge for five minutes
before the majority of the top organic phase was discarded. The rest of the organic layer
was evaporated under a soft stream of nitrogen gas, leaving aqueous phase at the
bottom of the glass tube. Phosphate buffer (20 μL) was added to the aqueous sample
before transferring into an autosampler vial.
C. Clozapine Extraction Method C (Edno et al., 1997)
Extraction method C was performed by Edno et al., (1997) to quantify clozapine and N-
desmethylclozapine in human plasma by HPLC with ultraviolet detection. Loxapine was
added as internal standard. This method differs from the previous methods by using
hexane-isoamyl alcohol mixture as the extraction solvent. This assay, with a few
modifications, was performed in the study in comparison with other clozapine extraction
methods.
Working standard, 600 μL and working internal standard (protriptyline hydrochloride), 50
μL, were pipetted into 10 mL screw-capped glass tube, followed by addition of 200 μL of
0.33 M sodium hydroxide. This mixture was extracted with 6 mL of hexane-isoamyl
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alcohol (985:15 v,v) and shaken vigorously for two minutes. The preparation was
centrifuged for 5 minutes at 3500 rpm. Organic phase was then transferred to a clean
10 mL screw-capped glass tube and back extracted into 200 μL of potassium
dihydrogen phosphate buffer (45 mM, pH 2.8). Centrifuge for 5 minutes before the
majority top organic phase was discarded. The remaining organic layer was evaporated
under a soft stream of nitrogen gas. The aqueous phase was transferred into an
autosampler vial.
D. Clozapine Extraction Method D (D’Arrigo et al., 2006)
This liquid-liquid extraction method was employed by D’Arrigo et al., (2006) for
determining olanzapine in human plasma by reversed-phase HPLC with ultraviolet
detection. Clozapine was used in this assay as an internal standard. Ten percent
isoamyl alcohol in hexane (10:90 v,v) was used in this method, whereas 1.5% isoamyl
alcohol in hexane- was used in clozapine extraction method C.
Working standard (600μL) and 50 μL of working internal standard (protriptyline
hydrochloride) were aliquoted into a 10 mL screw-capped glass tube and 200 μL of 0.33
M sodium hydroxide was added. The solution was extracted by shaking vigorously with
6 mL of hexane-isoamyl alcohol (90:10 v,v) for two minutes. This mixture was
centrifuged for 5 minutes at 3500 rpm. The organic phase was transferred to another
clean 10 mL screw-capped glass tube and then back extracted into 200 μL of potassium
dihydrogen phosphate buffer (45 mM, pH 2.8). The mixture was centrifuged for 5
minutes and then the top organic layer was discard. The remaining organic layer was
evaporated under a soft stream of nitrogen gas, leaving the aqueous phase in the
bottom of the glass tube. The aqueous phase with 200 μL of phosphate buffer was then
transferred into an autosampler vial.
2.2.3 Determination of Clozapine and N-desmethylclozapine by Capillary
Electrophoresis
The capillary zone elctrophoresis (CZE) analysis was performed using a 3D Capillary
Electrophoresis System, Model G1602A from Agilent Technologies (Palo Alto, CA, USA)
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with a diode array detector. Analysis was carried out by using a homemade fused-silica
capillary (polymicro technologies L.L.C.), total length of 33 cm (effective length 24.5 cm),
and internal diameter of 50 μm or 75 μm. The electrophoretic data were acquired with a
3D capillary electrophoresis (CE) ChemStation (Rev. A.10.02[1757]) equipped with a
HP workstation controlled by windows software.
The capillary electrophoresis machine was initialised once before the analysis. The
initialisation turns on the ultraviolet light, calibrates the wavelength and checks the vial
lifts.
The capillary was preconditioned by flushing with 0.1 M NaOH for 30 minutes, deionised
water for 20 minutes and phosphate buffer for 10 minutes before starting the analysis.
The capillary was also preconditioned by flushing 0.1 M of NaOH for 1 minute,
deionised water for 1 minute, and phosphate buffer for 1 minute before each run. For a
new capillary, 1 M of NaOH was flushed through for 30 minutes prior to the capillary
preconditioning process. The capillary was washed with isopropanol for 20 minutes at
the end of analysis.
The CE tray was setup with eight standard vials (contained 700 μL of liquid) from
position one to position eight in the following sequence; 1 M NaOH, 0.1 M NaOH,
phosphate buffer (positions three to five), IPA, waste vial, and deionised water. Samples
were placed from position nine onward. The sample tray was equilibrated at room
temperature. The detection was carried out by the on-capillary measurement of UV
absorption at 210 nm.
2.2.4 Determination of Clozapine and N-desmethylclozapine by High
Performance Liquid Chromatography
Analysis of clozapine was performed using the method published by Volpicelli et al.,
(1993) and Lovdahl et al., (1991). A reversed-phase liquid chromatographic C8 column
with photodiode array detection at 254 nm was used in this assay. The dimension of the
column is 150x4.6 mm. The mobile phase contained 310 mL of potassium dihydrogen
phosphate buffer, 190 mL of acetonitrile and 1 g of 1-heptanesulphonic acid. Extracted
sample (50 μL) was injected into the HPLC and the mobile phase was pumped through
the column at a flow rate of 1.5 mL per minute. A mixture of methanol: water (50:50 v,v)
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was pumped through the column for 5 minutes at end of analysis to clean the column,
followed by methanol for 10 minutes.
2.3 Statistical Analysis
Results present in this thesis were acquired from single experiments representing a
minimum of two experiments (unless otherwise stated). The mean and standard
deviation of each data point were calculated from triplicate analysis. Statistical analyses
were carried out by using PRISM software (version 4.00, GraphPad Software, Inc). The
comparison between treatments of significance was calculated by one-way analysis of
variance (ANOVA), where p < 0.05 indicated as not significant, and p < 0.01 indicated
significant difference between two comparisons. Method validator (version 1.1.10.0)
was used to performed linear regression plots and difference plots for comparisons
between HPLC and CE.
Chapter 3 Results
26
RESULTS
3.1 Optimizing clozapine separation for capillary electrophoresis by
adjusting the following conditions:
3.1.1 BGE Concentration
An initial study by Fujiwara and Honda (1986), had demonstrated that different salt
concentration of a back ground electrolyte (BGE) will affect the migration time of a
solute, as well as the chromatography resolution of peaks. This indicated that the
velocity of the EOF can be affected by the ionic strength of a BGE. Since the solute’s
mobility and the EOF are sensitive to pH changes, Buffer is an important parameter in
CZE. It provides the stability for minor pH changes, and also provides the ionic strength
for electrical conductivity to occur. This study was carried out to compare the
effectiveness of different phosphate buffer concentrations to the clozapine separation by
CZE. A 4000 nM clozapine working solution was made with crystallised clozapine in
50% methanol. The working solution of this concentration is equivalent to the maximum
clozapine concentration in human plasma. Phosphate buffer ranging from 20 to 100 mM
were compared, and the buffer was prepared of one part of sodium dihydrogen
phosphate solution with one part of phosphoric acid in distilled water. The phosphate
buffer will be address as BGE from now on.
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Figure 3.1.1 The effectiveness of different BGE concentration to the
clozapine separation by CZE
Different BGE concentrations were compared ranging from 20 to 100 mM. A number of
conditions were kept constant in this experiment; 50 μm (i.d) fused-silica capillary was used,
BGE pH of 2.5, temperature at 20 oC, apply voltage at 10 kV, sample injection of 20 kV per 2
seconds, operating at a wavelength of 210 nm. The average peak area was calculated as
absorbance multiplied by the clozapine migration time. Each data point represents the mean ±
SE of triplicate analysis.
The BGE at 40 mM exhibited an average peak area of 70.17 mAU*s (CV= 4%) for
clozapine separation. Diluted and concentrated BGE demonstrated decreases in the
peak area (Figure 3.1.1). Band broadening was observed for clozapine separation as
BGE concentrations of 80 mM or above were used (data not shown). This was possibly
due to the increase in BGE viscosity, which resulted in decreasing the EOF. There was
no result obtained from the BGE concentration of 100 mM. This study demonstrated
that BGE at 40 mM is the best condition for clozapine separation using a 50 μm (i.d)
fused-silica capillary. Therefore, BGE concentration of 40 mM was used for all
subsequent experiments in determining the optimal condition for clozapine separation.
3.1.2 BGE pH
The EOF in CZE is extremely sensitive to pH, consequently, the BGE pH is the most
important experimental parameter. BGE pHs 1.5 and 3.0 showed dramatic decreases in
average peak area with a value of 24.25 mAU*s (CV= 58%), and 24.16 mAU*s (CV=
87%) respectively. BGE pH 2.5 demonstrated an average peak area of 70.17 mAU*s
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(CV= 4%), whereas BGE pH 2.0 showed an average peak area of 62.86 mAU*s (CV=
11%) (Figure 3.1.2). ANOVA analysis showed no significant difference between BGE pH
2.0 and pH 2.5 (p > 0.05), however, the use of BGE at pH 2.0 demonstrated a high
value of CV (CV= 11%). This indicated that the EOF and zeta potential was unstable
with the BGE at pH 2.0, which means the reproducibility using BGE pH 2.0 is relatively
low. Therefore, BGE pH 2.5 was chosen for use in all following experiments determining
the optimal condition for clozapine separation using CZE.
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Figure 3.1.2 The effectiveness of different BGE pHs in the clozapine
separation by CZE
Different BGE pHs were compared, ranging from pH 1.5 to 3.0. The clozapine concentration
was 4000 nM. A number of conditions were kept constant in this experiment; 50 μm (i.d) fused-
silica capillary was used, BGE concentration of 40 mM, temperature at 20 oC, voltage at 10 kV,
sample injection of 20 kV per 2 seconds, and operating at a wavelength of 210 nm. Average
peak area was calculated as absorbance multiplied by the clozapine migration time. Each data
point represents the mean ± SE of triplicate analysis.
3.1.3 Temperature
The temperature of a capillary during CZE analysis is also an important factor that can
have an influence on the EOF. This is because the temperature is inversely proportional
to the viscosity of the BGE, and it is the major parameter that controls a solute’s
migration time (Equation 5). A temperature of 22 oC for clozapine separation showed an
average peak are of 70.13 mAU*s (CV= 6%), whereas 24 oC exhibited an average peak
area of 60.05 mAU*s (CV= 14%) (Figure 3.1.3). ANOVA analysis showed that there is
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no significant difference between temperatures of 22 oC and 24 oC (p < 0.05). However,
as the temperature elevated, the viscosity of the BGE reduced, and the current
increased. This disrupted the EOF, and may result in an inconstant thermal gradient
through the capillary, consequently, band broadening occurred at high temperatures
(data not shown) of 24 0C and above. In contrast, low BGE temperatures increased the
viscosity and reduced the injection volume compared to high temperatures. This might
be the reason for lower peak areas obtained from temperatures of 20 0C and below.
Therefore, a temperature of 22 0C was used for all subsequent experiments in
determining the optimal condition for clozapine separation by CZE.
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Figure 3.1.3 The effectiveness of different temperatures on the clozapine separation
by CZE
Different temperatures from 18 to 28 oC were compared. The clozapine concentration was 4000
nM. A number of conditions were kept constant in this experiment; 50 um (i.d) fused-silica
capillary was used, BGE concentration of 40 mM (pH 2.5), voltage at 10 kV, sample injection of
20 kV per 2 seconds, and operating at a wavelength of 210 nm. Average peak area was
calculated as absorbance multiplied by the clozapine migration time. Each data point represents
the mean ± SE of triplicate analysis.
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3.1.4 Applied Voltage
When voltage is applied to CZE, current will be generated through the free ions of BGE.
This separates the analytes by their charge to mass ratio. Therefore, the control of
applied voltage is also an important parameter in CE. In theory, maximum theoretical
plates can be achieved by applying the voltage as high as possible (Equation 6). In
practice, disruption of EOF occurs when high voltage is applied to CE.
Five different voltages were applied and compared for clozapine separation. There was
no separation at 5 kV, and the maximum separation was achieved when 10 kV was
applied with an average peak area of 45.53 mAU*s (CV= 2%). As the applied voltage
increased, the average peak area decreased (Figure 3.1.4). Although the migration time
was reduced by the use of higher voltage, unstable current, disrupted baseline and low
signal to noise ratio were observed when 20 kV and 25 kV were applied to the CE (data
not shown).
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Figure 3.1.4 The comparison between different applied voltages to the clozapine
separation by CZE
Different applied voltages were adjusted from 5 kV to 25 kV. The clozapine concentration was
4000 nM. The following conditions were kept constant in this experiment; 50 um (i.d) fused-silica
capillary was used, BGE concentration of 40 mM (pH 2.5), sample injection of 20 kV per 2
seconds, and operating at a wavelength of 210 nm. Average peak area was calculated as
absorbance multiplied by the clozapine migration time. Each data point represents the mean ±
SE of triplicate analysis.
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The final optimal conditions for clozapine separation were determined from the above
studies. These include, the BGE concentration, BGE pH, temperature, and applied
voltage. Table 3.2.1 is a summary of the optimal condition for clozapine separation
using a 50 μm (i.d) fused-silica capillary.
BGE Concentration 40 mM
BGE pH 2.5
Temperature 22 0C
Applied Voltage 10 kV
Table 3.1.1 A summary of the optimal CZE condition for clozapine separation
A summary of the optimal CZE condition for clozapine separation by using a 50 μm fused-silica
capillary. Clozapine concentration of 4000 nM was used for these studies. Each sample was
injected by electrokinetic injection at 20 kV per two seconds. The on-line UV detection
wavelength was at 210 nm.
3.2 Clozapine and N-desmethylclozapine separation using the
optimal conditions
To confirm the optimal conditions for clozapine and N-desmethylclozapine separation by
CZE, the following experiments were carried out by using the optimal conditions
determined from the previous studies (Figure 3.2.1). Three different concentrations of
clozapine and N-desmethylclozapine were analysed; 1000, 2000, and 4000 nM. Figure
3.2.1 showed a linear increment in the peak area as the concentration increased. This
indicated that the optimal conditions were giving a proportional response to
concentration.
N-desmethylclozapine displayed slightly higher peak area values for the three
concentrations than the values obtained for clozapine. However, ANOVA analysis
showed no significant difference between clozapine and N-desmethylclozapine average
peak areas for each concentration (p < 0.05). The migration times for clozapine and N-
desmethylclozapine were 4 and 3.8 minutes respectively. Protriptyline hydrochloride, as
an ISD, was introduced in this study. The migration time for protriptyline was 6 minutes.
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A linear relationship was found for both clozapine and N-desmethylclozapine, with an r2
value of 0.979 and 0.989 respectively (Figure 3.2.1).
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Figure 3.2.1 The standard curve for clozapine and N-desmethylclozapine separation
using CZE
Three different clozapine and N-desmethylclozapine concentrations were analysed, 1000, 2000
and 4000 nM. The optimal conditions were applied in this experiment; 50 μm (i.d) fused-silica
capillary was used, BGE concentration of 40 mM, BGE pH 2.5, voltage at 10 kV, sample
injection of 20 kV per 2 seconds, and operating at a wavelength of 210 nm. Average peak area
was calculated as absorbance multiplied by the clozapine migration time. Each data point
represents the mean ± SE of triplicate analysis.
3.3 A comparison of protocols for plasma clozapine and N-
desmethylclozapine extraction
Clinical drug monitoring for schizophrenic patients is relatively important as clozapine
has been reported to induce side effects, such as agranulocytosis and hypotension
(Amsler et al., 1977). The method of CZE was developed for the clinical measurement
of clozapine and N-desmethylclozapine levels in human plasma. Serum spiked with
clozapine was used for the following studies to confirm the effectiveness of the above
method. Drug free serum was donated from hemachromatosis patients as the blank
serum sample. The optimal plasma level of clozapine was determined from many
studies, ranging from 1000-4000 nM (Hiemke et al., 2000 and Ulrich et al., 2003).
Therefore, serum spiked with clozapine was made in three concentrations, 1000, 2000,
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and 4000 nM as a standard. Six hundred μL of each sample was extracted by extraction
method A. The samples were injected into CE by electrokinetic injection at 20 kV 2 s-1.
The result showed a linear relationship; as the clozapine concentration increased, the
average peak area also increased. However, the sensitivities were reduced two to six
folds when compared with he results obtained from the working solution, which was
clozapine in 50% methanol (data not shown). It was not certain whether the loss of
sensitivity was due to the serum extraction method or the detection of CE. Ninety
percent of clozapine is protein bound, therefore, there is a possibility that only partial
clozapine was extracted during the process.
To investigate this further, three separate experiments were carried out to confirm
whether the loss of sensitivity was due to the protein bound clozapine. Serum samples
were exposed to acidic or alkaline solution in order to adjust the serum pH. This was
carried out to break the hydrocarbon and nitrogen bonding between clozapine and
proteins prior to the extraction process. Ten μL of 15% trichloroacetic acid (TCA) and
0.1 M sodium bicarbonate was used to adjust the pH to extremely acidic (pH1.7) or
extremely alkaline (pH 8.7). The use of TCA was also to precipitate serum proteins
before the extraction. Acetonitrile was introduced in this study to precipitate proteins as
well, and the result was compared with the use of TCA. However, the outcome of this
experiment showed no significant improvement to the sensitivity of clozapine separation
by CZE (data not shown). The electropherogram exhibited low sensitivity and resolution.
An extra peak was observed ten seconds before clozapine by using acetonitrile for
protein precipitation during the extraction. This observation indicated that acetonitrile
may have discharged a methyl group from the benzodiazepine ring of clozapine during
the extraction process, which resulted in the formation of N-desmethylclozapine.
Therefore, four different types of liquid-liquid extraction protocol using different
extraction solvents were investigated and compared.
Clozapine extraction methods A, B, C, and D were carried out using ethyl acetate,
dicloromethane, 1.5% and 10% hexane-isoamylid alcohol as extraction solvents. The
results showed a linear relationship between peak area and clozapine concentration
(Figure 3.3.1). However, there were no significant differences found between the four
methods at each data point (p < 0.05). This indicated that the loss of sensitivity during
clozapine separation using CZE may not be due to partial clozapine being extracted.
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Figure 3.3.1 The comparison of four different extraction methods for clozapine
separation by CZE
Four different extraction methods were compared. Clozapine concentrations of 1000, 2000 and
4000 nM were analysed. Thirty μL of protriptyline hydrochloride (internal standard - 25 mg/L)
was used in this experiment. The following conditions were kept constant; 50 μm (i.d) fused-
silica capillary was used, BGE concentration of 40 mM (pH 2.5), voltage at 10 kV, sample
injection of 20 kV for 2 seconds, and operating at a wavelength of 210 nm. Average peak area
was calculated as absorbance multiplied by the clozapine migration time. Each data point
represents the mean ± SE of triplicate analysis.
3.4 Increasing the sensitivity of capillary electrophoresis for
clozapine detection
It was found the extraction method was not responsible for the low sensitivity detection
for CZE from the previous study. Therefore, in order to increase the sensitivity, several
methods can be investigated. These include adjusting the sample injection value and
increasing the optical pathlength of a capillary by either using a high sensitivity cell or a
capillary wider in internal diameter. The use of a high sensitivity cell is further discussed
in section 4.3.
Sample loading of CE was performed by electrokinetic injection in this study. The
amount of sample injected was controlled by applying high voltage for a certain time,
which supported the elctroosmotic migration of the BGE. In order to increase the
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amount of sample injected into the capillary, the voltage was raised from 20 kV 2s-1 to
25 kV 2s-1. The results exhibited band broadening and tailing (data not shown). The
reason for this observation was possibly due to sample overloading. Therefore, the
sample injection was fine tuned to 23 kV 1.5s-1. The outcome of this adjustment did not
resolve the low sensitivity problem, nevertheless, the resolution of the peaks was
significantly increased.
It was therefore decided to increase the optical pathlength of the capillary by using a 75
μm (i.d.) fused-silica capillary in order to increase the detection sensitivity. A capillary
with a wider internal diameter not only increases the optical pathlength, but also
increases the loading capacity of a capillary. The result shows a linear relationship
between the average peak area and clozapine concentration (Figure 3.4.1). By using a
75 μm (i.d.) fused-silica capillary for clozapine separation a two to six fold improvement
of the detection limit was exhibited when compared to a standard 50 μm (i.d) capillary (p
< 0.01). The electropherogram showed improvement in the sensitivity and resolution
and the migration time was also shortened to 3.68 minutes (Figure 3.4.2). Regression
analysis of 0.983 when using the 75 μm (i.d.) capillary, and 0.947 using the 50 μm (i.d.)
capillary were obtained. Therefore, a 75 μm (i.d.) fused-silica capillary was used for all
subsequent studies.
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Figure 3.4.1 The comparison between the use of two separate capillaries different in
internal diameter
Two separate capillaries were compared, one is a standard capillary with 50 μm internal
diameter, and a 75 μm in internal diameter. Clozapine concentrations of 1000, 2000 and 4000
nM were analysed. Fifty μL of protriptyline hydrochloride (internal standard - 25 mg/L) was used
in this experiment. The following conditions were kept constant; BGE of 40 mM (pH 2.5), apply
voltage at 10 kV, sample injection of 23 kV for 1.5 seconds, and operate at a wavelength of 210
nm. Average peak area was calculated as absorbance multiplied by the clozapine migration
time. Each data point represents the mean ± SE of triplicate analysis.
Chapter 3 Results
37
Figure 3.4.2 The electropherogram for the comparison between two different types of
capillary for clozapine separation
Clozapine concentrations of 4000 nM were analysed. Internal standard, protriptyline, analysed
by 75 μm (peaks 1 & 3 ) and 50 μm (peaks 2 & 4) capillary. The following conditions were kept
constant; BGE concentration of 40 mM, BGE pH 2.5, apply voltage at 10 kV, sample injection of
23 kV for 1.5 seconds, and operate at a wavelength of 210 nm.
The use of a 75 μm (i.d.) capillary not only increased the internal diameter but the EOF
was also different compared to the standard capillary (50 μm i.d.). The BGE
concentration, hence the ionic strength, influences the EOF, and also the viscosity of
the medium inside a capillary (Equation 4). The viscosity of the medium also depends
on the capillary diameter, therefore, an experiment was carried out to compare the
effect of using different BGE concentrations with a 75 μm (i.d.) capillary. BGE
concentrations of 40, 60 and 80 mM were compared. Serum spiked with clozapine was
extracted by method A. The result showed a linear correlation between the peak area
and clozapine concentration (Figure 3.4.3); as the BGE concentration increased, the
average peak area also increased. The ANOVA analysis showed that there was no
significant difference between the use of 60 and 80 mM BGE for each data point (p <
0.05). However, there are significant differences between 40 and 60 mM BGEs used for
clozapine concentrations of 2000 and 4000 nM (p < 0.01). Furthermore, the arrow in
figure 3.4.4 indicates peak tailing for the use of 80 mM, therefore, it was decided to use
a BGE at a concentration of 60 mM for all later experiments using a 75 μm (i.d.)
capillary.
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Figure 3.4.3 The effectiveness of different BGE concentrations to the clozapine
separation by using a 75 μm (i.d.) capillary
Different BGE concentrations were compared ranging from 40 to 80 mM. Clozapine
concentration of 1000, 2000, 4000 nM were analysed. Thirty μL of protriptyline hydrochloride
(internal standard - 25 mg/L) was used in this experiment. A number of conditions were kept
constant in this experiment; 75 μm (i.d) fused-silica capillary was used, BGE pH of 2.5,
temperature at 22 oC, apply voltage at 10 kV, sample injection of 23 kV per 1.5 seconds, and
operate at a wavelength of 210 nm. Average peak area was calculated as absorbance
multiplied by the clozapine migration time. Each data point represents the mean ± SE of
triplicate analysis.
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Figure 3.4.4 The electropherogram for the comparison between three different
BGE concentrations
The electropherogram for clozapine separation by using a 75 μm (i.d.) fused-silica capillary with
BGE concentration of 40 mM (peaks 1 & 4), 60 mM (peaks 2 & 5), and 80 mM (peaks 3 & 6).
Peak 1-3 are clozapine, and peak 4-6 are the internal standard. Clozapine concentrations of
4000 nM were analysed. The following conditions were kept constant; BGE pH 2.5, apply
voltage at 10 kV, sample injection of 23 kV for 1.5 seconds, and operate at a wavelength of 210
nm.
Table 3.2.1 is a summary of clozapine and N-desmethylclozapine separations using a
75 μm (i.d.) fused-silica capillary. Two sets of serum spiked samples were analysed
with three different concentrations, 1000, 2000, and 4000 nM. The recovery percentage
was calculated by dividing the observed concentration with the spiked concentration
and multiplied by one hundred. The intra-assay CV % was calculated as the ratio of the
standard deviation and the mean, multiplied by one hundred. The recovery and intra-
assay represent one set of samples, each with triplicate runs, whereas the inter-assay
was calculated by combining two sets of samples.
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Concentration
(nM)
Recovery
±SD (%)
Intra-assay
CV (%) (n=3)
Inter-assay
CV (%) (n=9)
Clozapine 1000 97 ± 1.1 0.9 3.1
2000 107 ± 1.6 0.7 1.2
4000 100 ± 0.8 1.2 1.4
N-desmethylclozapine 1000 89 ± 1.2 1.9 4.7
2000 100 ± 4.6 0.8 1.7
4000 98 ± 2.0 2.5 2.0
Table 3.4.1 A summary from the determination of clozapine level from spiked
standard by using the optimal conditions for CZE
A summary of the final CZE condition for clozapine separation by using a 75 μm fused-silica
capillary. Clozapine concentration of 1000, 2000 and 4000 nM was used for this study. Each
result represents a triplicate analysis. BGE of 60 mM (pH 2.5), and apply voltage at 10 kV was
used in this study. Each sample was injected by electrokinetic injection at 23 kV per 1.5
seconds. The on-line UV detection wavelength was at 210 nm.
3.5 The comparison of high performance liquid chromatography
and capillary electrophoresis for clozapine and N-
desmethylclozapine analysis
Patients’ samples were investigated using the final method developed from the previous
experiments.CZE was performed using a 75 μm (i.d.) fused-silica capillary, BGE
concentration of 60 mM and pH of 2.5 at a temperature of 22 oC. 10 kV was applied
during the separation, and each sample was injected at 23 kV per 1.5 seconds. One
hundred and eight patients’ samples were analysed by CZE using these parameters.
Nine hundred μL of each sample was extracted by extraction method A. The clozapine
concentration was calculated as the ratio of the clozapine to the internal standard peak
area, and compared to the standard ratio stored in the integrator. The results gained by
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CZE were compared to the HPLC analysis. N-desmethylclozapine was not analysed
here because analyses of this metabolite are not performed in the Canterbury Health
Laboratory. A regression line of 1.100 was obtained from a linear graph of the results
gained from CE versus the results analysed by HPLC (Figure 3.5.1). The X axis is the
clozapine concentration gained by HPLC method, and the Y axis is the result gained
from CE analysis. The equality line is demonstrated in a dashed line (x=y), and the
regression line shown here as a solid line. The graph showed regression line bias to the
left of the graph.
Intercept : -43.4 [ -146.8 to 59.9 ]
Slope : 1.100 [ 1.041 to 1.160 ]
Unweighted linear regression N= 108
Linear Regression Polt for HPLC against CE
0 1000 2000 3000 4000 5000
HPLC(nM)
0
1000
2000
3000
4000
5000 CE (nM)
Figure 3.5.1 The comparison between clozapine separation by CZE and HPLC
A 75 μm (i.d.) fused-silica capillary was used for the CZE study. Fifty μL of protriptyline
hydrochloride (internal standard - 25 mg/L) was used. The following conditions were kept
constant for CZE method; BGE concentration of 60 mM, BGE pH 2.5, apply voltage at 10 kV,
sample injection of 23 kV for 1.5 seconds, and operated at a wavelength of 210 nm. Brownless
RP-8 5 micron column were used for HPLC. The flow rate of mobile phase was 1.5 mL per
minute, and operated at a wavelength of 254 nm.
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A difference plot was performed by method validator (Figure 3.5.1). Each point indicates
the difference between the two analytical methods, HPLC and CE. The X axis indicates
the mean result, and the Y axis is the differences between these two methods. This
graph shows the majority of differences between the two methods lie between +800 and
-400 nM. It also shows a trend for the difference to increase with the magnitude of the
measurement. This indicates that larger discrepancies between these two methods
occur at higher clozapine concentrations.
Mean difference : 108 [ 53 to 163 ]
Difference plot N= 108
Linear Regression Polt for HPLC against CE
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Figure 3.5.2 The difference plot for the comparison between clozapine separation by
CZE and HPLC
A difference plot with 95% limits of agreement (dash line) was plotted with the same
experimental conditions as above. Each point is the difference between concentrations for
HPLC and CE analysis, and was plotted against the mean of each patient’s sample.
Seven separate external quality control (EQC) samples from the Cardiff Bioanalytical
services were analysed by CE for both clozapine and N-desmethylclozapine. The CE
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results were compared with HPLC. Figure 3.5.3 shows the liner regression graph and
difference graph for clozapine and N-desmethylclozapine comparisons between CE and
HPLC. The linear regression graph (a) for clozapine analysis shows bias toward the
right of the equality line, indicating the result obtained from HPLC is slightly higher than
CE, whereas the linear regression line bias is towards the left of the equality line for N-
desmethylclozapine (b). The difference plot for clozapine showed small discrepancies
throughout all concentrations. The differences lie between +200 and -200 nM for
clozapine, but between +100 and -300 nM for N-desmethyclozapine. The difference plot
(b) shows that large discrepancies between HPLC and CE occurred at low
concentration levels.
(a) Clozapine
Intercept : -61.8 [ -186.7 to 63.2 ]
Slope : 1.008 [ 0.920 to 1.096 ]
Unweighted linear regression N = 7
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(b) N-desmethylclozapine
Intercept : 10.0 [ -148.8 to 168.8 ]
Slope : 1.043 [ 0.864 to 1.222 ]
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0 400 800 1200 1600 2000 2400
HPLC
0
400
800
1200
1600
2000
2400 CE
Mean difference : -54.3 [ -139 to 30.3 ]
Difference plot N = 7
0 1000 2000 3000 4000
Mean
-300
-200
-100
0
100
200 Difference
Figure 3.5.3 The linear regression plots and difference plots for external quality
control samples
Experimental conditions were same as above. Seven external quality control samples were
analysed by CE and compared to HPLC results. The linear regression plot and difference plot
for clozapine (a) and N-desmethylclozapine (b) are performed with 95% limits of agreement.
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DISCUSSION
4.1 The optimal condition for clozapine separation by capillary
electrophoresis
4.1.1 Overview of capillary electrophoresis
CE is a fast and powerful separation technique for the analysis of charge molecules,
amino acid, peptides, proteins, and compounds. It is a simple automatic technique that
has many advantages over the traditional gel electrophoresis. Analytes are separated
by the strong force of EOF based on the differences of their charge to mass ratios. The
on-line electronic sample detection of CE is similar to HPLC, where the output results
are represent as chromatography. However, CE is fundamentally based on
electrophoresis.
The use of bare glass capillary in CE was found to have a high potential for analyte and
protein absorption to the capillary wall. This solute-wall interaction results in dissentious
zeta potential across the capillary, and consequently alters the EOF (Towns 1992).
Binding of solute to the capillary wall may lead to band broadening, band tailing and
irreproducible results. Furthermore, bare glass capillary is extremely fractured, hence
difficult to install. Other types of capillary such as, pyrex borosilicate, fused silica, and
teflon capillary were investigated in detail. Lukacs and Jorgenson (1985) demonstrated
pyrex borosilicate capillary could not be use in an analysis at a wavelength shorter than
280 nm. The use of teflon capillary resulted in serious absorption of proteins, as well as
hydroxyl group and other anions from the medium. Moreover, teflon capillary also
exhibited poor thermal conductivity. The author concluded that fused silica capillary is
preferable for heat dissipation, and it is the better choice for short wavelength analysis
in CE. Fused silica capillary is now widely used in CE, and is the most preferable
capillary material, although it exhibits some solute-wall absorption. Capillary surface
modifiers, such as trimethylsilane, and cross linked methylcellulose were used in
conjunction with protein separation in order to reduce protein and solutes binding to the
fused silica capillary wall. However, in the case of clozapine separation, the additional of
a modifier is unnecessary, because clozapine has a low molecular weight (326.823 g
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Mol-1). Furthermore, the addition of a surface modifier in BGE has the potential to
reduce the separation migration time, due to the interaction with analytes.
A total capillary length of 33 cm with an effective length of 24.5 cm was used in this
study. The effective length is the distance from the injection end of capillary to the
detection window (Figure 1.5.1). For an efficient, fast separation, it is best to use a
capillary that is as short as possible (Equation 5). Since the molecular weight of
clozapine is small, 33 cm of capillary is sufficient for the separation. This is the minimum
length for the CE instrument used in this study.
The total mobility in a capillary is the sum of the electrophoretic mobility and the EOF
mobility. Several factors can influence the total mobility, which is the dielectric constant
of BGE, zeta potential, and the viscosity of the BGE (Equation 4). Thus, these factors
can be influenced by various parameters, such as the BGE concentration, BGE pH,
temperature, and applied voltage (Section 3.1). These parameters easily affect on the
analyte’s migration time and the efficiency of the separation (Equation 5 and 6).
Therefore, an optimal condition was determined in this study as the primary goal for the
clozapine and N-desmethylclozapine separation. Once the optimal condition was
confirmed, serum spiked with clozapine was analysed. Patients samples were analysed
using the final optimal condition for CZE and compared with the result obtained from
HPLC (Section 3.5).
4.1.2 BGE Concentration
An early study was done by Fujiwara and Honda in 1986, examining the effects of
different BGE concentration and pH on cinnamic acid and its analogues separation by
CE. It was found that as the salt concentration of BGE increased, the migration time of
analyte also increased. The separation of clozapine in this study also exhibited the
same observation seen in Fujiwara and Honda’s study (data not shown). The migration
time of clozapine for 40 mM and 60 mM BGE was 5 and 5.3 minutes respectively. As
the BGE concentration increased, the velocity of EOF decreased and hence increased
the migration time (Equation 5). This study also showed the ionic strength of BGE is
also correlating with the current. The current increased significantly as the BGE
concentration increased above 80 mM. This resulted in excessive background noise,
reducing the signal to noise ratio, low resolution and eventually band broadening (data
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not shown). This observation was possibly due to the Joule heating effect (further
discuss on section 4.1.5 and section 4.4).
There was no peak obtained by using 100 mM of BGE. The current was increased to
100 μA at this concentration. This resulted in increasing the viscosity of BGE, and
decreasing the EOF (Equation 3 and 4). Putting all these factors together, this
suggested that clozapine was either not separated during the run time course (10
minutes), or the BGE was too viscous for clozapine separation to occur. A paper
published by Gao et al, (2006) showed an example of phospholipids separation using a
high concentration of BGE. By taking the migration time and resolution into account, the
author decided to use the BGE concentration as low as 5 mM. In the case of clozapine
separation in this study, diluted BGE (ie. 20 mM) resulted in low conductivity, and less
viscosity, consequently the loading capacity was also reduced. Although the migration
time was reduced with 20 mM BGE, considering the peak area and efficiency of the
separation, it was decided to use 40 mM of BGE as the final condition (Figure 3.1.1).
4.1.3 pH of BGE
BGE pH is the most important parameter for selectivity in CZE. Since the EOF is related
to the dielectric constant of the BGE, the zeta potential and the viscosity of the BGE is
relatively important as well (Equation 4). Thus variation of the pH may lead to
differences of the EOF because the charged capillary surface wall is extremely sensitive
to pH changes. The EOF in a fused-silica capillary was found to exhibit a sigmoid
relationship with pH (Lukacs and Jorgenson, 1985; Lambert and Middleton, 1990). That
is, as the pH of BGE increases, the electroosmotic mobility also increased. Phosphate
buffer has a pKa of 2.1, therefore, BGE was prepared within its buffering range. pH of
1.5 to 3.0 was investigated in this study.
It was found pH between 2.0 and 2.5 demonstrated the best condition for clozapine
separation. However, pH at 2.0 demonstrated variable and irreproducible results.
Therefore it was decided to use pH 2.5 as the final condition. The peak area and
resolution was small and low for the use of BGE at pH 1.5. This is due to the
suppressed silanol group at the capillary wall, resulting in reducing the EOF
approximate to zero. The current was drawn up to 150 μA, and irreproducible
separation was seen in this study.
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At high pH, the silanol groups at the surface of capillary are fully ionised. This generated
strong zeta potential, which resulted from the dense electrical double layer (Figure
1.5.3). Consequently, the EOF increased as the pH of BGE increased. In the end, the
migration time also increased with pH, and band broadening was seen as the pH
elevated (Fujiwara and Honda, 1986; Gao et al., 2006). The same effect was also
observed in this study for the BGE pH at 3.0 (Figure 3.1.2). However, this result was
contradictory to the result obtained from a clozapine separation study by Hillaert et al
(2004). Hillaert et al has successfully separated clozapine by using BGE pH 3.5. This
was probably due to the high concentration of BGE which was used in their study.
Hillaert et al used BGE at a concentration 80 mM which reduced the EOF in theory, and
eventually the EOF was increased to maintain the EOF mobility since BGE pH 3.5 was
used. This could explain the reason why BGE pH 3.0 demonstrated a low peak area,
because a low concentration of BGE (40 mM) was used in this study.
4.1.4 Temperature
Temperature in CZE is an important parameter which is inversely proportional to the
viscosity of BGE, thus influences the total mobility of BGE in a capillary (Equation 3 and
4). When high voltage is applied to the CE, heat will be generated as a function of
current. It was estimated the electrophoretic mobility increases by two percent per one
degree in temperature. The temperature in the center can be predicted to be higher
than at both ends of the capillary. This creates an axial temperature gradient during the
separation process. Since the BGE in the middle region is less viscous than the outer
region near to the wall, a viscosity gradient will also result from a radial temperature
gradient. Therefore, the BGE is sensitive to the temperature, and it can influence the
migration time of an analyte, as well as the selectivity and efficiency of the analysis
(Grushka et al., 1989; Jorgenson and Lukacs, 1983; Xuan and Li, 2005).
Research work from the early stage of CE development has suggested that capillary
should be thermostated. The temperature effect was investigated and cautiously
controlled in this study by adjusting the thermostat from 18 to 28 0C. The result showed
both 22 and 24 0C demonstrated the best condition for clozapine separation. However,
due to the large variations seen for 24 0C (CV = 14%) the temperature of 22 0C was
used for the final optimal condition (Figure 3.1.3).
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Reijenga et al (2007) have demonstrated the use of phosphate BGE at different
temperatures for p-aminobenzonic and o-aminobenzonic enantiomers separation. It was
found the migration time roughly decreased 0.7 second when the temperature
increased from 15 0C to 25 0C. In the case of this study, the migration time was only
decreased 0.3 second with the 10 0C difference. The peak shapes and baseline noise
showed no differences for Reijenga’s aminobenzonic separations when the temperature
was elevated, even up to 45 0C, whereas in this study, when the temperature was
elevated above 24 0C, the background noise increased, and band broadening was
observed. The observations seen in this study were somehow different compared to
Rejienga’s result. This might possibly be due to the differences of analytes and BGE’s
pKa value. Moreover, the temperature gradients model proposed by Grushka et al
(1989) showed that the radial temperature effects are negligible for narrow capillaries,
(i.e. 50 μm i.d.) therefore, the band broadening observed at higher temperature in this
study might be due to the development of axial temperature gradients, generated by
nonuniform electric field across the capillary. A pressure gradient might also be
developed during the process in order to maintain the EOF. This axial thermal gradient
effect is often seen in CZE with thermostatting due to the use of short capillary, where
both ends of the capillary were left outside of the cartridge for sample injection and
maintaining the EOF flow (Xuan and Li, 2005).
4.1.5 Applied Voltage
Assuming the molecular diffusion is the only source of zone broadening in a capillary,
equation 6 has demonstrated by applying the highest voltage, maximum efficiency of
separation can be achieved. According to equation 5, the capillary length does not
directly influence the efficiency of a separation but it does affects the migration time of
the analyte. Therefore, in theory, it is expected to apply the highest voltage to the
shortest capillary during method development. In reality, it is impractical to use high
voltage because of the thermal effects. It is because the shorter capillary has less
surface area for heat dissipation. As a result, band broadening, disrupted baseline, and
nonuniform EOF will occur due to Joule heating effect (Jorgenson and Lukacs, 1983).
When an electric field is applied, current will be generated by the flow of ions from BGE.
Thus Joule heating is the by product of current flowing through the resistant BGE inside
the capillary. As a consequence, the internal temperature will increase, and the viscosity
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of the BGE will decrease. Therefore, Joule heating effects can interfere with the total
mobility and affect the efficiency of the separation (Equation 3, 4, and 6).
Joule heating effects were observed in this study when 20 kV or above was applied to
the CZE system. When the applied voltage increased to 20 kV, the migration time
decreased to 2.1 seconds. The current raised over 70 μA and the peak area decreased
dramatically (Figure 3.1.4). Unstable current, disrupted baseline and low signal to noise
ratio were observed throughout the analysis. The same effect was also seen for 25 kV
as applied voltage with the addition of band broadening. Moreover, the migration time
was decreased to 1.6 seconds, and the current was raised to 90 μA. The reason for
decreasing migration time is because the electro-osmotic mobilities were increased as
the applied voltage elevated (Cross and Gao, 1999). There was no peak obtained by
using 5 kV (Figure 3.1.4). This is probably due to the low electric field applied which
resulted in low current. As a consequence, the ion flow of BGE was not rapid enough for
analytes zone broadening inside the capillary. Thus, the separation did not occur.
4.2 A comparison of protocols for plasma clozapine and N-
desmethylclozapine extraction
The optimal condition for a working solution of clozapine separation was determined
from the previous experiments by using a 50 μm (i.d.) fused silica capillary, as
described in Table 3.1.1. To confirm this optimal condition for clozapine and N-
desmethyclozapine separation by CE, three different concentrations of working
solutions were investigated, 1000, 2000 and 4000 nM. The result showed a r2 value of
0.979 and 0.989 for clozapine and N-desmethylclozapine respectively (Figure 3.2.1).
This indicates the average peak area increased as a function of the drug concentration.
When serum spiked with clozapine and N-desmethylclozapine was separated by this
optimal condition, the result demonstrated two to six fold decrement in sensitivity when
compared to the working solutions (data not shown). To investigate further whether the
lost of sensitivity was due to the extraction process, four extraction protocols were
compared (Section 2.2.2). Method A is the current clozapine extraction method carried
out in the Canterbury Health Laboratory, whereas extraction methods B, C, and D were
from literature. Serum spiked with clozapine was analysed in three concentrations, 1000,
2000 and 4000 nM. The results showed no significant differences (p < 0.05) for each
Chapter 4 Discussion
50
data point when these four methods were compared. This indicated the lost of
sensitivity may be due to other reasons, possibly the limit of detection of CE.
CE is a highly efficient separation technique, and it is very sensitive to even a slight
change of BGE or analyte composition. Serum sample was extracted and reconstituted
in 50% methanol. In theory, the result of serum spiked sample would recover from the
standard solution which only consists of clozapine with 50% methanol. However, in
practical analysis, the analyte injected into CE was more viscous than the standard
solution. This was possibly due to lipids and impurities carried over during the extraction
process, resulting in a different matrix than standard solution. Therefore, capillary
blockage was often seen when a 50 μm (i.d.) capillary was used. The sudden drop of
current to zero was a sign of capillary blockage.
4.3 Increasing the sensitivity of capillary electrophoresis for
clozapine detection
The sample volume injected onto CE was estimated as 1000 fold smaller than HPLC.
Moreover, the use of narrow capillary has 100 times less detection pathlength in
comparison to a HPLC column (Hempel, 2000). Therefore, the sensitivity of detection
has always been the greatest barrier for the development of CE. There are various
other reasons for the low sensitivity and low resolution. These may include the binding
of solutes to the capillary wall, which resulted in band broadening, limited loading
capacity or short optical pathlength of the capillary.
In order to investigate whether the loss of sensitivity was due to the solute-wall
interaction, 1M NaOH and IPA was introduced to flush the capillary between each run to
diminish possible precipitate formation at the side of capillary wall. However, the result
showed no significant improvement in the clozapine separation (p>0.05). Furthermore,
flushing strong NaOH and IPA between runs resulted in irreproducible resolution and
efficiency, and variable migration time (data not shown). This may be due to the
disrupted EOF by strong solvent during the analysis.
Beer-Lambert’s law stated that the absorbance is directly proportional to the molar
extinction coefficient, the pathlength of the capillary, and the concentration of the
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solution. According to the theory, the absorbance will increase with the increment of
optical pathlength of a capillary. To improve the detection limits of the CE, a high
sensitivity cell (Agilent Technologies) was introduced in this study to increase the
sensitivity for clozapine separation by CZE. Mrestani and Neubert (2000) have
demonstrated thiamine separation using a high sensitivity cell. The results showed the
detection limit was improved up to nine fold compared to a standard capillary. In this
study, the result showed an improvement of twenty fold when a high sensitivity cell was
introduced to the CZE. However, irreproducible and variable results were obtained (data
not shown). Longer migration time was also required for the use of a high sensitivity cell
for clozapine separation.
It was finally decided to use a 75 μm (i.d.) capillary to increase the limits of detection.
The use of a wider capillary provided a longer detection pathlength, and permited a
larger sample size. Furthermore, a wider capillary has less potential for capillary
blockage, and it is easier to wash out any impurities left over in the capillary during the
analysis. Furthermore, it was suggested that a wider capillary has smaller surface to
volume ratio, thus solute-wall interaction may be reduced. Loading capacity will also be
increased by using a wider capillary (Grushka et al., 1989). The results showed a two
to six fold increase in the detection limit compared to the 50 μm (i.d.) capillary (Figure
3.4.1; Figure 3.4.2).
4.4 Increasing the sensitivity of capillary electrophoresis using a 75
μm (i.d.) capillary
As discussed in section 4.1, temperature and applied voltage affected the migration
time and resolution of a CZE system, whereas BGE pH affects the selectivity of a
separation analysis. The BGE concentration is the major parameter that would influence
many factors, such as the migration time, the resolution and the efficiency. Possible
Joule heating may have occurred when the applied voltage was above 20 kV. Axial
temperature gradient generation might be the reason for band broadening and reducing
signal to noise ratio at high temperature. Figure 3.1.2 showed a distinct value of BGE at
pH 2.5 is the best condition for clozapine selectivity. Therefore, when the narrow
capillary was replaced with a wider internal diameter capillary (75 μm), the BGE pH,
temperature and the applied voltage were kept constant but three different BGE
concentrations were compared for the use of a new wider capillary.
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The result showed both 60 mM and 80 mM of BGE concentration demonstrated the
best condition for clozapine separation using a 75 μm (i.d.) capillary (Figure 3.4.3).
However, the electropherogram exhibited peak tailing and band broadening when the
80 mM of BGE was used (Figure 3.4.4).
Joule heating is a function of time, voltage applied, cross section area of a capillary, and
the total length of a capillary (Rathore, 2004). Thus there is a potential to increase the
joule heating effect by increasing the capillary inner diameter. Furthermore, Joule
heating effect was also found to be a function of phosphate BGE concentration from
100 to 210 mM (Cross and Cao, 1999). The author has also mentioned that Joule
heating is negligible for low BGE concentrations (ie. 25 to 75 mM). Their experiments
were done using a 50 μm (i.d.) capillary. However, possible Joule heating effect was
found in this study using 75μm (i.d.) capillary with BGE concentration of 80 mM. This
finding is some what contradictory to the results obtained from Cross and Cao’s study.
A high concentration of BGE has more conductivity than dilute BGE, which draws higher
current and produces more heat. Consequently, band broadening by Joule heating
effect possibly occurred in this study.
Table 3.4.1 is a summary of clozapine and N-desmethylclozapine separation results
using the optimal condition for CZE analysis with a 75 (i.d.) capillary. Drug free serums
were spiked with clozapine and N-desmethylclozapine in three concentrations, 1000,
2000, and 4000 nM. The recovery percentages ranged from 89 to 107 percent. The
intra-essay coefficient of variation percentage (CV%) represent in triplicate analysis of
the same sample and the inter-essay represent in three different samples with the same
concentration. The CV% for both clozapine and N-desmethylclozapine are 0.8-2.5% for
the intra-essay, and 1.2–4.7% for the inter-essay. These results are acceptable as the
CV% are less than 10%. This indicates the developed CE essay is validated for
clozapine and N-desmethylclozapine separation.
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4.5 The comparison of high performance liquid chromatography
and capillary electrophoresis for clozapine and N-
desmethylclozapine analysis
One hundred and eight patients’ samples were analysed by CE and compared with the
HPLC results. Due to time constraints and sample quantity, the HPLC results for
comparison were obtained from the Canterbury Heath Laboratory toxicology’s routine
work. The clozapine separation results were compared and plotted into a linear
regression plot (Figure 3.5.1). The graph demonstrated a straight line with a r2 value of
1.100 and slightly biased to the left of the equality line. This indicated the results gained
from CE are generally higher in value compared to HPLC. The difference plot (Figure
3.5.2) indicated a larger discrepancy occurred at high clozapine concentration. There
were three samples which had a result of +800 nM difference compared to HPLC.
Roughly 85% of the samples were under 2500 nM for clozapine, and more than 90% of
the results were within +700 nM and -400 nM differences.
The External Quality Control (EQC) program involves various clinical laboratories world
wide. There are roughly 70 and 60 laboratories which contribute to the EQC program for
clinical clozapine and N-desmethylclozapine measurement respectively every month.
Roughly 70% of these laboratories are using HPLC as their primary method. The
objective of the EQC program is to strengthen the performance of each laboratory
involved in this program, and ensure the validity of the results obtained by their methods.
Seven EQC samples from 2007 to 2008 (stored at -20 0C) were analysed by CE, and
compared with the HPLC results gathered worldwide. The results were compared by a
linear regression plot and a difference plot for clozapine (a) and N-desmethylclozapine
(b) (Figure 3.5.3). The linear regression graph shows a r2 value of 1.008 for clozapine
and 1.043 for N-desmethylclozapine. The data are within 95% of agreement. The
difference plot for clozapine demonstrated a difference between +200 and -200 nM
compared to HPLC, and N-desmethylclozapine had a difference between +100 and -
300 nM. The results obtained from EQC demonstrated a small discrepancy between CE
and HPLC, whereas the patients’ sample comparison demonstrated a larger
discrepancy at high concentration. This is due to the small sample size from ECQ
program resulting in small variations. However, combining these two comparisons, it
has been shown that clozapine and N-desmethylclozapine separation by CE is a valid
method that can replace HPLC.
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4.6 Instrumental Issues
CE has shown to be a more cost effective technique in terms of the solvent use for
clozapine and N-desmethylclozapine essay compared to HPLC. Although CE is
performed in a simple system which does not encounter sophisticated problems in this
study, there are still some disadvantages involved with CE. Although the capillary was
flushed with strong NaOH before each experiment, it was found solute-wall absorption
within the capillary can still build up over time. Solute-wall absorption is commonly found
with fused-silica capillary, and may result in band broadening. Therefore, a new
capillary each month is recommended for daily analysis. Furthermore, the use of 75 μm
(i.d.) capillary generates more waste due to the greater amount of analyte and reagents
going through the capillary. It is recommended that a new waste vial is necessary every
10 runs, since the capacity of a standard vial is only 800 μL. A new deionised water vial,
0.1M NaOH vial, and one of the BGE vial (for flushing between runs) are also needed to
after 30 runs.
4.7 Summary
An assay for clinical clozapine and N-desmethylclozapine was developed in this study
using CE as a more cost effective technique compared to HPLC. The optimal condition
for CZE was found to use a 75 μm (i.d.) fused-silica capillary, which provides a longer
detection pathlength and permits a larger sample size. This improves the detection limit
of the CE. The final CE separation technique was compared with HPLC over 108
patient’s samples, and seven EQC samples. The results demonstrated clozapine and
N-desmethylclozapine separation by CE is a validated method.
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